| 28077790 |
FLT3 activating mutations display differential sensitivity to multiple tyrosine kinase inhibitors
Levis, M,
Nguyen, B,
Williams, AB,
Small, D,
Brown, P,
Li, L,
Young, DJ,
Ma, H
|
Oncotarget |
2017 |
| 19541823 |
KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation
Shimizu, M,
Ishikawa, Y,
Ishii, K,
Shiotsu, Y,
Minami, Y,
Tanizaki, R,
Akiyama, T,
Ozeki, K,
Akinaga, S,
Kanda, Y,
Mori, Y,
Umehara, H,
Kiyoi, H,
Naoe, T,
Abe, A,
Maeda, H,
Sato, Y
|
Blood |
2009 |
